Prostanoids vs placebo
The review found no eligible studies for this question.
- no estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
PGE1 showed no clear difference in ulcer healing compared with inositol niacinate (low certainty).
The review found no eligible studies for this question.
Iloprost showed no clear difference in total amputations compared with PGE1 (low certainty).
The review found no eligible studies for this question.
Iloprost probably leads to higher adverse events (participants) compared with PGE1 (moderate certainty).
Iloprost showed no clear difference in rest‐pain relief compared with PGE1 (low certainty).
Iloprost showed no clear difference in ulcer healing compared with PGE1 (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Prostanoids probably leads to higher adverse events (participants) compared with placebo (moderate certainty).
Clinprost showed no clear difference in adverse events compared with lipo‐PGE1 (moderate certainty).
Clinprost showed no clear difference in rest‐pain relief compared with lipo‐PGE1 (low certainty).
Clinprost showed no clear difference in ulcer healing compared with lipo‐PGE1 (low certainty).
Prostanoids probably leads to higher rest‐pain relief (dichotomous) compared with placebo (moderate certainty).
Prostanoids probably leads to higher ulcer healing compared with placebo (moderate certainty).
The review found no eligible studies for this question.
It is very uncertain whether prostanoids changes total amputations compared with pentoxifylline (very low certainty).
The review found no eligible studies for this question.